Extended spectrum β lactamases (ESBL) production in Acinetobacter baumannii strains isolated from Chilean hospitals belonging to VIII region;Producción de β-lactamasas de espectro extendido (BLEE) en cepas de Acinetobacter baumannii aisladas en hospitales de la VIIIa región, Chile

Revista Chilena de Infectologia

Volumn 24, Issue 2, 2007, Pages 137-141

  Pino I , Carolina ^a   Domínguez Yévenes, Mariana ^a   González R , Gerardo ^a   Bello T , Helia ^a   Sepúlveda A , Marcela ^a   Mella M , Sergio ^a   Zemelman M , Claudia ^b   Zemelman Z , Raúl ^b  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

Acinetobacter; Amp C; Extended spectrum lactamases

Indexed keywords

EID: 34248325169     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Fisher J F, Meroueh S O, Mobashery S. Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. Chem Rev 2005; 105: 395-424.
2. Jacoby G A, Muñoz Price L S. The new β-lactamases. N Engl J Med 2005; 352: 380-91.
3. Sánchez M, Bello H, Domínguez M, Mella S, Zemelman R, González G. Transferencia de β-lactamasas de espectro extendido desde cepas hospitalarias de Klebsiella pneumoniae a otras especies de enterobacterias. Rev Méd Chile 2006; 134: 415-20.
4. Bush K, Jacoby G A, Medeiros A A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-33.
5. Sanders C C. β-lactamases of Gram negative bacteria: new challenges for new drugs. Clin Infect Dis 1992; 1089-99.
6. Jenkins S G. Mechanisms of bacteria antibiotic resistance. New Horizons 1996; 4: 321-32.
7. Yang Y, Bhachech N, Bradford P, Jett B D, Sahm D F, Bush K. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 β- lactamases from St. Louis, Missouri. Antimicrob Agents Chemother 1998; 42: 1671-6.
8. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G. The Italian ESBL Study Group. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: Implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 2002; 46: 196-202.
9. st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
10. Hooper D C. Efflux pumps and nosocomial antibiotic resistance: A primer for hospital epidemiologists. Clin Infect Dis 2005; 40: 1811-7.
11. Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005; 56: 20-51.
12. Nitzan Y, Deutsch E B, Pechatnikov I. Diffusion of β-lactam antibiotics through oligomeric or monomeric porin channels of some Gram-negative bacteria. Curr Microbiol 2002; 45: 446-55.
13. Philippon A, Arlet G, Jacoby G A. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemotherapy 2002; 46: 1-11.
14. Bello H, Trabal N, Ibáñez D, Reyes A, Domínguez M, Mella S et al. β-lactamasas de familias diferentes a TEM y SHV en cepas de Klebsiella pneumoniae subespecie pneumoniae aisladas en hospitales chilenos. Rev Méd Chile 2005; 133: 737-9.
15. National Committee for Clinical Laboratory Standards. Performance Standard for Antimicrobial Susceptibility Testing; Thirteenth Informational Supplement. NCCLS document M100-S13 (M2). NCCLS, Wayne, Pennsylvania, USA, 2003.
16. Ho P L, Chow K H, Yuen K Y, Ng W S, Chau PY. Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 1998; 42: 49-54.
17. O'Callaghan C H, Morris A, Kirby M S, Shingler A H. Novel method for detection of β-lactamase by using a chromogenic-cephalosporins substrate. Antimicrob Agents Chemother 1972; 1: 283-8.
18. Tenover F C, Huang M B, Rasheed J K, Persing D H. Development of PCR assays to detect ampicilin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae. J Clin Microbiol 1994; 32: 2729-37.
19. Nüesch-Inderbinen M T, Hachler H, Kayser F H. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E-test. Eur J Clin Microbiol Infect Dis 1996; 15: 398-402.
20. Vahaboglu H, Ozturk R, Aygun G, Coskunkan F, Yaman A, Kaygusuz A, et al. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997; 41: 2265-9.
21. Vahaboglu H, Ozturk R, Akbal H, Saribas S, Tansel O, Coskunkan F. Practical approach for detection and identification of OXA-10-derived ceftazidime-hidrolyzing extended-spectrum β-lactamases. J Clin Microbiol 1998; 36: 827-9.
22. Joly-Guillou M L. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11: 868-73.
23. Bello H, González G, Domínguez M, Zemelman R, García A, Mella S. Activity of selected β-lactams, ciprofloxacin and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals. Diagn Microbiol Infect Dis 1997; 28: 183-6.
24. Amyes S G B, Young H K. Mechanisms of antibiotic resistance in Acinetobacter spp genetics of resistance. Bergogne-Bérézin E, Joly-Guillou M L, Towner K J, editors. Acinetobacter, microbiology, epidemiology, infections, management. CRC Press, Boca Raton, Fla; 1996, p. 185-224.
25. Poirel L, Karim A, Mercat A, Le Thomas I, Vahaboglu H, Richard C, et al. Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J Antimicrob Chemother 1999; 43: 157-8.
26. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003; 41: 3542-7.
27. Clinical Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI document M100-S15. CLSI, Wayne, Pennsylvania, USA, 2005.
28. Truppia LA, Mollerach A, Di Conza JA, Radice M, Mugna V, Méndez E, et al. Comparación de tres métodos microbiológicos para la detección de betalactamasas de espectro extendido en enterobacterias aisladas en Santa Fe (Argentina). Enferm Infecc Microbiol Clin 2005; 23: 525-8.
29. Bello H, González G, Domínguez M, Valenzuela L, Zemelman C, Mella S, et al. Detection of extended-spectrum β-lactamases produced by Chilean isolates of Klebsiella pneumoniae by two synergy methods. J Chemother 2004; 16: 312-4.
30. Pasteran F, Rapoport M, Petroni A, Faccone D, Corso A, Galas M, et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother 2006; 50: 3222-4.
31. Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y. Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol 2004; 42: 3978-84.
32. Courvalin P. Evasion of antibiotic action by bacteria. J Antimicrob Chemother 1996; 37: 855-69.
33. Diomedi A. Infecciones por Acinetobacter baumannii pan-resistente. Consideraciones epidemiológicas y de manejo antimicrobiano actualizado. Rev Chil Infect 2005; 22: 298-320.